Celecoxib in Parkinson Disease as Adjuvant Therapy
NCT07246278
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
80
Enrollment
OTHER
Sponsor class
Conditions
Parkinson Disease
Interventions
DRUG:
Levodopa Carbidopa
DRUG:
Celecoxib 200mg
Sponsor
Tanta University